ADXN · Addex Therapeutics Ltd. · Documents
Market Cap
$3.65M
Shares
1.27M
Volume · Oct 5
5904
Avg daily vol (3M)
187.79K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-10-02 | — | |
| 6-K | 2026-09-28 | 2026-06-30 | |
| 6-K | 2026-09-25 | — | |
| 6-K | 2026-08-26 | — | |
| 6-K | 2026-07-08 | — | |
| 6-K | 2026-06-30 | — | |
| 6-K | 2026-06-25 | — | |
| 6-K | 2026-06-05 | — | |
| 20-F | 2026-05-15 | 2025-12-31 | |
| 6-K | 2026-04-30 | — | |
| 6-K | 2026-04-29 | — | |
| 6-K | 2026-04-23 | — | |
| 6-K | 2026-04-21 | — | |
| 6-K | 2026-02-03 | — | |
| 6-K | 2026-01-07 | — | |
| 6-K | 2025-12-10 | — | |
| 6-K | 2025-12-04 | — | |
| 6-K | 2025-10-29 | — | |
| 6-K | 2025-09-30 | 2025-06-30 | |
| 6-K | 2025-09-23 | — | |
| 6-K | 2025-06-30 | — | |
| 6-K | 2025-06-25 | — | |
| 6-K | 2025-06-20 | — | |
| 6-K | 2025-06-06 | — | |
| 20-F | 2025-05-15 | 2024-12-31 | |
| 6-K | 2025-05-12 | — | |
| 6-K | 2025-04-30 | — | |
| 6-K | 2025-04-25 | — | |
| 6-K | 2025-04-17 | — | |
| 6-K | 2024-11-22 | — | |
| 6-K | 2024-11-12 | 2024-11-11 | |
| 6-K | 2024-09-30 | — | |
| 6-K | 2024-09-19 | — | |
| 6-K | 2024-08-27 | — | |
| 6-K | 2024-07-22 | — | |
| 6-K | 2024-07-15 | — | |
| 6-K | 2024-07-01 | — | |
| 6-K | 2024-06-06 | — | |
| 6-K | 2024-06-05 | — | |
| 6-K | 2024-04-29 | — | |
| 6-K | 2024-04-18 | — | |
| 20-F | 2024-04-18 | 2023-12-31 | |
| 6-K | 2024-04-03 | — | |
| 6-K | 2024-01-30 | — | |
| 6-K/A | 2023-12-21 | 2023-06-30 | |
| 6-K | 2023-12-20 | — | |
| 6-K | 2023-12-14 | — | |
| 6-K | 2023-11-29 | — | |
| 6-K | 2023-11-28 | — | |
| 6-K | 2023-11-14 | — |
Showing 1–50 of 134 filings